Cargando…
Overview of the Premarketing and Postmarketing Requirements for Drugs Granted Japanese Conditional Marketing Approval
For drugs that are intended to fill unmet medical needs, such as the treatment of rare diseases or a subtype of cancer, it can take a long time to conduct confirmatory clinical trials due to limited patient availability. Delayed access to these drugs increases the risk of mortality of patients with...
Autores principales: | Matsushita, Shunsuke, Tachibana, Keisuke, Kusakabe, Tetsuya, Hirayama, Ryuichi, Tsutsumi, Yasuo, Kondoh, Masuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212755/ https://www.ncbi.nlm.nih.gov/pubmed/33048440 http://dx.doi.org/10.1111/cts.12898 |
Ejemplares similares
-
Postmarket Clinical Evidence for High-Risk Therapeutic Medical Devices Receiving Food and Drug Administration Premarket Approval in 2010 and 2011
por: Rathi, Vinay K., et al.
Publicado: (2020) -
A Concept for a Japanese Regulatory Framework for Emerging Medical Devices with Frequently Modified Behavior
por: Ota, Nagomi, et al.
Publicado: (2020) -
Reporting of Study Participant Demographic Characteristics and Demographic Representation in Premarketing and Postmarketing Studies of Novel Cancer Therapeutics
por: Varma, Tanvee, et al.
Publicado: (2021) -
Time Series Analysis of the Effectiveness and Safety of Capsule Endoscopy between the Premarketing and Postmarketing Settings: A Meta-Analysis
por: Iijima, Kazuo, et al.
Publicado: (2016) -
Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018
por: Rathi, Vinay K, et al.
Publicado: (2023)